Carmat S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALCAR.PA research report →
About the company
Carmat SA specializes in engineering and creating a full artificial heart, specifically designed for individuals worldwide who are afflicted with severe, late-stage biventricular heart failure. The company commenced operations in 2008 and is based in Vélizy-Villacoublay, France.
- CEO
- Stephane Piat
- IPO
- 2010
- Employees
- 162
- HQ
- Vélizy-Villacoublay, FR
Price Chart
- Market Cap
- $6.36M
- P/E
- -0.04
- P/S
- 0.91
- P/B
- -0.04
- EV/EBITDA
- -1.19
- Div Yield
- 0.00%
- Gross Margin
- -336.56%
- Op Margin
- -702.86%
- Net Margin
- -734.29%
- ROE
- 106.81%
- ROIC
- -185.69%
- Revenue
- $7.00M · 145.79%
- Net Income
- $-51,400,000 · 4.58%
- EPS
- $-2.26 · 4.24%
- Op Income
- $-49,200,000
- FCF YoY
- 23.39%
- 52W High
- $1.51
- 52W Low
- $0.09
- 50D MA
- $0.15
- 200D MA
- $0.59
- Beta
- 1.02
- Avg Volume
- 797.17K
Get TickerSpark's AI analysis on ALCAR.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALCAR.PA coverage
Recent articles, reports, and earnings notes.
No research on ALCAR.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALCAR.PA report →Similar companies
Peers in the same neighborhood.